Skip to main navigation Skip to search Skip to main content

Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study

  • Jacqueline A. Seiglie
  • , Edson Serván-Mori
  • , Jennifer Manne-Goehler
  • , James B. Meigs
  • , J. Jaime Miranda
  • , Sandra G. Sosa-Rubí
  • , Omar Silverman-Retana
  • , Deborah J. Wexler
  • , Veronika J. Wirtz
  • Massachusetts General Hospital
  • Harvard Medical School
  • National Institute of Public Health
  • Universidad Peruana Cayetano Heredia
  • The George Institute for Global Health
  • Aarhus University Hospital
  • Boston University School of Public Health

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Aims: We sought to investigate whether individuals with diabetes have a higher likelihood of testing positive for SARS-CoV-2, as a proxy for infection risk, than individuals without diabetes. Methods: We conducted a cross-sectional study of publicly available data among a Mexican population, totaling 2,314,022 adults ≥ 18 years who underwent SARS-CoV-2 testing between March 1 and December 20, 2020. We used 1:1 nearest neighborhood propensity score matching by diabetes status to account for confounding among those with and without diabetes. Results: In the overall study population, 1,057,779 (45.7%) individuals tested positive for SARS-CoV-2 and 270,486 (11.7%) self-reported diabetes. After propensity score matching, patient characteristics were well-balanced, with 150,487 patients in the diabetes group (mean [SD] age 55.9 [12.7] years; 51.3% women) and 150,487 patients in the no diabetes group (55.5 [13.3] years; 50.3% women). The strictest matching algorithm (1:1 nearest neighbor) showed that compared to individuals without diabetes, having diabetes was associated with 9.0% higher odds of having a positive SARS-CoV-2 test (OR 1.09 [95% CI: 1.08–1.10]). Conclusions: Presence of diabetes was associated with higher odds of testing positive for SARS-CoV-2, which could have important implications for risk mitigation efforts for people with diabetes at risk of SARS-CoV-2 infection.

Original languageEnglish
Article number108953
JournalDiabetes Research and Clinical Practice
Volume178
DOIs
StatePublished - Aug 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study'. Together they form a unique fingerprint.

Cite this